Rgenta Therapeutics
Roger Sun is Vice President of Matrix Partners China, focusing on investment in the healthcare sector.
Prior to joining Matrix, Roger had many years of experiences in managing investments in private equity and venture capital firms, and had established business insights in biotech, medical service, IVD and internet healthcare. Roger graduated from Fudan University with a B.Sc. degree of Pharmacy.
This person is not in the org chart
This person is not in any offices
Rgenta Therapeutics
Rgenta Therapeutics is developing a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus on oncology and neurological disorders.